Clinical Trials

NCT04545736 | RECRUITING | PHASE1/PHASE2
56 participants

Oral Metformin for Treatment of ABCA4 Retinopathy

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2020-11-23
Completion:
2028-09-30
Conditions
  • ABCA4 Retinopathy
  • Stargardt Disease
  • Retinal Dystrophy
  • Retinal Degeneration
Interventions
  • DRUG
No Results Yet
NCT04407754 | ACTIVE_NOT_RECRUITING | NA
168 participants

Myo-Inositol for Infertility in PCOS

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2022-02-07
Completion:
2026-12-31
Conditions
  • Polycystic Ovary Syndrome
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT04354246 | COMPLETED | PHASE1
94 participants

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2020-03-31
Completion:
2026-04-01
Conditions
  • Advanced Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Colon Cancer
  • Plasma Cell Neoplasm
  • Multiple Myeloma
  • HNSCC
  • Microsatellite Stable Colorectal Carcinoma
  • MSS-CRC
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
NCT04338893 | COMPLETED | NA
252 participants

ROSA Total Knee Post Market Study EMEA

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2020-12-15
Completion:
2025-08-22
Conditions
  • Knee Pain
  • Chronic Osteoarthritis
  • Avascular Necrosis of the Femoral Condyle
  • Moderate Varus, Valgus or Flexion Deformities
  • Rheumatoid Arthritis
Interventions
  • PROCEDURE
NCT04205409 | COMPLETED | PHASE2
20 participants

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2020-06-05
Completion:
2024-09-20
Conditions
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Grade 3a Follicular Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Plasma Cell Myeloma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Marginal Zone Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Plasma Cell Myeloma
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
Interventions
  • BIOLOGICAL
NCT04144907 | RECRUITING | NA
40 participants

Protein Needs Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2021-04-26
Completion:
2030-09-30
Conditions
  • Colorectal Cancer
  • Breast Cancer
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT04106856 | ACTIVE_NOT_RECRUITING | PHASE1
22 participants

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer (SHAPER)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2019-08-08
Completion:
2024-12-06
Conditions
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Locally Advanced Unresectable Pancreatic Adenocarcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage IIA Pancreatic Cancer AJCC v8
  • Stage IIB Pancreatic Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
Interventions
  • RADIATION
  • DRUG
No Results Yet
NCT04042558 | COMPLETED | PHASE2
150 participants

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-12
Start Date:
2019-09-26
Completion:
2021-10-22
Conditions
  • NSCLC Stage IIIB
  • NSCLC Stage IV
  • EGFR Gene Mutation
  • ALK Gene Rearrangement Positive
  • ROS1 Gene Mutation
Interventions
  • DRUG
NCT04025515 | SUSPENDED
500 participants

Molecular Profiling Project

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-12
Start Date:
2019-01-11
Completion:
2026-12-25
Conditions
  • Lung Cancer
  • Non-Small Cell Lung Cancer
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page